MARKET

PODD

PODD

Insulet Corp
NASDAQ
148.88
+4.98
+3.46%
After Hours: 149.51 +0.63 +0.42% 19:07 06/24 EDT
OPEN
144.83
PREV CLOSE
143.90
HIGH
149.63
LOW
144.82
VOLUME
1.40M
TURNOVER
--
52 WEEK HIGH
354.88
52 WEEK LOW
138.79
MARKET CAP
10.31B
P/E (TTM)
34.65
1D
5D
1M
3M
1Y
5Y
1D
1 Mid-Cap Stock Worth Your Attention and 2 We Question
Barchart · 1d ago
DexCom, Insulet gain news Buys at Deutsche Bank despite recent selloff
Seeking Alpha · 1d ago
Can Insulet’s (PODD) Closed-Loop Type 2 Data Reframe Its Long-Term Diabetes Tech Narrative?
Simply Wall St · 1d ago
S&P 500 Movers: SNDK, AXON
NASDAQ · 1d ago
This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Benzinga · 1d ago
Insulet Price Target Announced at $190.00/Share by Deutsche Bank
Dow Jones · 1d ago
Deutsche Bank Initiates Coverage On Insulet with Buy Rating, Announces Price Target of $190
Benzinga · 1d ago
Insulet initiated with a Buy at Deutsche Bank
TipRanks · 1d ago
More
About PODD
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.

Webull offers Insulet Corp stock information, including NASDAQ: PODD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PODD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PODD stock methods without spending real money on the virtual paper trading platform.